The case for fetal cardiac intervention

Area of Science:

• Cardiology
• Fetal Medicine
• Congenital Heart Disease

Background:

• Congenital heart disease (CHD) surgery is increasingly performed in early infancy due to higher mortality and myocardial damage in delayed cases.
• Unoperated or delayed-surgery children with CHD face significant risks, including increased mortality and myocardial damage.

Purpose of the Study:

• To explore fetal cardiac intervention as a potential extension of early CHD treatment.
• To evaluate the feasibility of intervening in fetuses with critical semilunar valve stenosis or atresia.
• To assess the potential of early ventricular decompression to alter disease progression and improve postnatal outcomes.

Main Methods:

• Review of existing data and proposed strategies for fetal cardiac intervention.
• Consideration of early ventricular decompression techniques.
• Evaluation of in utero balloon atrial septostomy for specific fetal cardiac conditions.

Main Results:

• Early ventricular decompression may halt CHD progression and improve myocardial health.
• Intervention could preserve two-ventricle circulation or enhance single-ventricle candidate outlook.
• In utero balloon atrial septostomy may stabilize fetuses with a closed interatrial septum, preventing circulatory failure, hydrops, and intrauterine death.

Conclusions:

• Fetal cardiac intervention, including early ventricular decompression and atrial septostomy, shows promise for improving outcomes in CHD.
• Proactive in-utero treatment may alter the natural history of critical fetal heart conditions, leading to better postnatal results.
• Preserving myocardial health and pulmonary bed development through fetal intervention is crucial for optimizing long-term CHD management.